TY - JOUR
T1 - Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES)
T2 - Optic Neuritis Incidence Between 2015-2020
AU - Rodríguez-Rodríguez, Camilo Andrés
AU - Cifuentes-González, Carlos
AU - Mejía-Salgado, Germán
AU - Garzón-Dangond, Juan Manuel
AU - Verbel-Yaneth, Angie Vanessa
AU - Machado-Galindo, Sofia
AU - Cruz-Reyes, Danna Lesley
AU - de-la-Torre, Alejandra
N1 - Publisher Copyright:
© 2023 Taylor & Francis Group, LLC.
PY - 2024
Y1 - 2024
N2 - Purpose: To estimate the incidence of Optic Neuritis (ON) in Colombia using data from the national health registry between January 1, 2015, and December 31, 2020. Methods: A population-based study was conducted using the Integrated Social Protection Information System from the Colombian Ministry of Health and the International Classification of Diseases-10 code for ON to estimate the incidence of ON from 2015 to 2020. We also evaluated the impact of the COVID-19 lockdown on the epidemiology of the disease in 2020. Finally, a standardized morbidity rate map was created to assess a country’s ON geographic distribution. Results: From 2015 to 2019, 2,463 new cases of ON were reported. The overall 5-year incidence rate was 1.56 cases per 100,000 inhabitants per year, 66% of the patients were females. The peak of presentation in males was the quinquennium of 50–54 years, and in females, it was 45–49 years. In 2020, coinciding with the COVID-19 pandemic, there was a reduction in the incidence of ON by approximately 0.15 cases per 100,000 inhabitants. The regions with a high number of cases and an increasing risk of new cases were Bogotá, Antioquia, and Valle del Cauca. Conclusions: The incidence of ON in Colombia is lower compared to countries in the northern hemisphere, with women under 50 years being predominantly affected. The onset of the COVID-19 pandemic corresponded with a reduction in identifying new ON cases. This underscores governments’ need to implement effective diagnostic strategies in the future.
AB - Purpose: To estimate the incidence of Optic Neuritis (ON) in Colombia using data from the national health registry between January 1, 2015, and December 31, 2020. Methods: A population-based study was conducted using the Integrated Social Protection Information System from the Colombian Ministry of Health and the International Classification of Diseases-10 code for ON to estimate the incidence of ON from 2015 to 2020. We also evaluated the impact of the COVID-19 lockdown on the epidemiology of the disease in 2020. Finally, a standardized morbidity rate map was created to assess a country’s ON geographic distribution. Results: From 2015 to 2019, 2,463 new cases of ON were reported. The overall 5-year incidence rate was 1.56 cases per 100,000 inhabitants per year, 66% of the patients were females. The peak of presentation in males was the quinquennium of 50–54 years, and in females, it was 45–49 years. In 2020, coinciding with the COVID-19 pandemic, there was a reduction in the incidence of ON by approximately 0.15 cases per 100,000 inhabitants. The regions with a high number of cases and an increasing risk of new cases were Bogotá, Antioquia, and Valle del Cauca. Conclusions: The incidence of ON in Colombia is lower compared to countries in the northern hemisphere, with women under 50 years being predominantly affected. The onset of the COVID-19 pandemic corresponded with a reduction in identifying new ON cases. This underscores governments’ need to implement effective diagnostic strategies in the future.
UR - http://www.scopus.com/inward/record.url?scp=85205084795&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85205084795&partnerID=8YFLogxK
U2 - 10.1080/09273948.2023.2295538
DO - 10.1080/09273948.2023.2295538
M3 - Research Article
C2 - 38133944
AN - SCOPUS:85205084795
SN - 0927-3948
VL - 32
SP - 1749
EP - 1754
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
IS - 8
ER -